Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1986 1
1987 1
1988 4
1989 1
1990 3
1991 2
1992 6
1993 3
1994 5
1995 3
1996 4
1997 7
1998 2
1999 2
2000 2
2001 3
2002 3
2007 1
2013 2
2016 2
2018 1
2019 1
2020 1
2021 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension.
Chalasani N, Abdelmalek MF, Garcia-Tsao G, Vuppalanchi R, Alkhouri N, Rinella M, Noureddin M, Pyko M, Shiffman M, Sanyal A, Allgood A, Shlevin H, Horton R, Zomer E, Irish W, Goodman Z, Harrison SA, Traber PG; Belapectin (GR-MD-02) Study Investigators. Chalasani N, et al. Among authors: traber pg. Gastroenterology. 2020 Apr;158(5):1334-1345.e5. doi: 10.1053/j.gastro.2019.11.296. Epub 2019 Dec 5. Gastroenterology. 2020. PMID: 31812510 Free article. Clinical Trial.
Intestine-specific gene transcription.
Traber PG, Silberg DG. Traber PG, et al. Annu Rev Physiol. 1996;58:275-97. doi: 10.1146/annurev.ph.58.030196.001423. Annu Rev Physiol. 1996. PMID: 8815796 Review.
Molecular pathogenesis of colorectal cancer.
Hoops TC, Traber PG. Hoops TC, et al. Among authors: traber pg. Hematol Oncol Clin North Am. 1997 Aug;11(4):609-33. doi: 10.1016/s0889-8588(05)70453-6. Hematol Oncol Clin North Am. 1997. PMID: 9257148 Review.
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
Kishimoto TK, Fournier M, Michaud A, Rizzo G, Roy C, Capela T, Nukolova N, Li N, Doyle L, Fu FN, VanDyke D, Traber PG, Spangler JB, Leung SS, Ilyinskii PO. Kishimoto TK, et al. Among authors: traber pg. J Autoimmun. 2023 Oct 14;140:103125. doi: 10.1016/j.jaut.2023.103125. Online ahead of print. J Autoimmun. 2023. PMID: 37844543 Free article.
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110).
Kivitz A, DeHaan W, Azeem R, Park J, Rhodes S, Inshaw J, Leung SS, Nicolaou S, Johnston L, Kishimoto TK, Traber PG, Sands E, Choi H. Kivitz A, et al. Among authors: traber pg. Rheumatol Ther. 2023 Aug;10(4):825-847. doi: 10.1007/s40744-023-00546-0. Epub 2023 Apr 17. Rheumatol Ther. 2023. PMID: 37069364 Free PMC article.
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Baraf HSB, Khanna PP, Kivitz AJ, Strand V, Choi HK, Terkeltaub R, Dalbeth N, DeHaan W, Azeem R, Traber PG, Keenan RT. Baraf HSB, et al. Among authors: traber pg. Rheumatology (Oxford). 2024 Apr 2;63(4):1058-1067. doi: 10.1093/rheumatology/kead333. Rheumatology (Oxford). 2024. PMID: 37449908 Free PMC article. Clinical Trial.
Control of gene expression in intestinal epithelial cells.
Traber PG. Traber PG. Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29;353(1370):911-4. doi: 10.1098/rstb.1998.0255. Philos Trans R Soc Lond B Biol Sci. 1998. PMID: 9684288 Free PMC article. Review.
Gut patterning: the case of the missing cecum.
Traber PG. Traber PG. Gastroenterology. 1998 Aug;115(2):487-9. doi: 10.1016/s0016-5085(98)70214-8. Gastroenterology. 1998. PMID: 9758534 No abstract available.
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Curti BD, Koguchi Y, Leidner RS, Rolig AS, Sturgill ER, Sun Z, Wu Y, Rajamanickam V, Bernard B, Hilgart-Martiszus I, Fountain CB, Morris G, Iwamoto N, Shimada T, Chang S, Traber PG, Zomer E, Horton JR, Shlevin H, Redmond WL. Curti BD, et al. Among authors: traber pg. J Immunother Cancer. 2021 Apr;9(4):e002371. doi: 10.1136/jitc-2021-002371. J Immunother Cancer. 2021. PMID: 33837055 Free PMC article. Clinical Trial.
65 results